Author

E. S. Robertson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Ghosh· 1 shared A. Saha· 1 shared B. B. Das· 1 shared C. Gain· 1 shared J. You· 1 shared K. Sun· 1 shared P. Lieberman· 1 shared R. K. Singh· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Ghosh

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

KSHV-encoded vCyclin can modulate HIF1α levels to promote DNA replication in hypoxia

R. K. Singh, Y. Pei, Z. L. Lamplugh, K. Sun, Y. Yuan, P. Lieberman, J. You, E. S. Robertson

This study shows that KSHV-encoded vCyclin modulates HIF1α levels in hypoxia to promote DNA replication and cell proliferation.

bioRxiv · Aug 12, 2020Microbiology

Proteasomal Inhibition Triggers Viral Oncoprotein Degradation via Autophagy-Lysosomal Pathway

C. Gain, S. Malik, S. Bhattacharjee, A. Ghosh, E. S. Robertson, B. B. Das, A. Saha

This study shows proteasomal inhibition causes degradation of EBNA3A and EBNA3C viral oncoproteins via autophagy-lysosomal pathway, while EBNA3B remains stable, suggesting potential therapeutic use of proteasome inhibitors for EBV-related B-cell lymphomas.

bioRxiv · Sep 23, 2019Cancer Biology